Tapewire

Nasdaq · USD

ATEX

Anterix Inc.

Export transactions ↓
Tapewire entity
4597
SEC CIK
0001304492
Parsed reports
446

Last 12 months

Inside the activity.

2 purchase rows · 48 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202520
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 2026018
Jul 202600
Aug 2026013
Sep 2026011
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 01, 2021 Filed Feb 3, 2021 23:40 UTC
Schwartz Robert HarrisPresident and CEO
GrantCommon Stock 45,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-007474 · doc4.xml · nonDerivative · entry 1

Schwartz Robert Harris · CIK 0001654170 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,850

F1 · shares: The performance-based restricted stock units (the "Units") vest upon the Reporting Person's continued service and achievement of certain stock price levels calculated utilizing a four-year compound annual growth rate and based on the average closing bid price per share of the Issuer's common stock measured over a sixty (60) trading-day period. The Reporting Person may vest in a minimum of 25% of the target reported Units and up to a maximum of 350% of the target reported Units based on specified stock price levels. The vesting end measurement date is February 1, 2025, with earlier vesting determination dates upon a change in control of Issuer, the involuntary termination of the Reporting Person or twelve (12) months following the achievement of the maximum stock price level. If after February 1, 2023, the Reporting Person achieves a stock price level, there will be a vesting determination date the earlier of 12 months thereafter or February 1, 2025.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 23:20 UTC
Ashe Gena LGeneral Counsel & Secretary
GrantStock Option (Right to Buy) · Derivative 849 $0.00 Strike: $32.90 $0.00
Disclosure

SEC source: 0001209191-21-002814 · doc4.xml · derivative · entry 1

Ashe Gena L · CIK 0001669943 · General Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 849

Underlying: Common Stock · 849 shares

Expires 2031-01-07

F1 · derivative.exercise_date: The option shares vest and become exercisable in 2 equal annual installments measured from January 7, 2021.

Read SEC document
January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment
Ashe Gena LGeneral Counsel & Secretary
GrantStock Option (Right to Buy) · Derivative 0 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-21-003674 · doc4a.xml · derivative · entry 2

Ashe Gena L · CIK 0001669943 · General Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires 2031-01-07

F2 · derivative.exercise_date: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported.

F2 · balance_after: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported.

Read SEC document
January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment
Ashe Gena LGeneral Counsel & Secretary
GrantCommon Stock 849 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-003674 · doc4a.xml · nonDerivative · entry 1

Ashe Gena L · CIK 0001669943 · General Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,555

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest in 2 equal annual installments on January 7, 2022 and January 7, 2023.

Read SEC document
December 29, 2020 Filed May 3, 2021 20:50 UTC
OBRIEN MORGAN EDirector · Executive Chairman
GiftCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-029650 · doc5.xml · nonDerivative · entry 2

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,050

F1 · kind: These transactions represent gifts or charitable contributions by the Reporting Person.

Read SEC document
December 29, 2020 Filed May 4, 2021 00:52 UTC
Schwartz Robert HarrisDirector · President and CEO
GiftCommon Stock 1,058 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-029651 · doc5.xml · nonDerivative · entry 1

Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,792

F1 · kind: These transactions represent a charitable contribution by the Reporting Person.

Read SEC document
December 21, 2020 Filed Dec 23, 2020 18:13 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 31,667 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001209191-20-065071 · doc4.xml · derivative · entry 3

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,333

Underlying: Common Stock · 31,667 shares

Expires 2024-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shares are fully vested.

Read SEC document
December 21, 2020 Filed Dec 23, 2020 18:13 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 31,667 $40.17 $1,272,063.39
Disclosure

SEC source: 0001209191-20-065071 · doc4.xml · nonDerivative · entry 2

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,250

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.81. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
December 21, 2020 Filed Dec 23, 2020 18:13 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionCommon Stock 31,667 $20.00 $633,340.00
Disclosure

SEC source: 0001209191-20-065071 · doc4.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,917

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 16, 2020 Filed Dec 17, 2020 00:23 UTC
Guttman-McCabe ChristopherChief Reg & Comm Officer
SaleCommon Stock 1,590 $29.75 $47,302.50
Disclosure

SEC source: 0001209191-20-063906 · doc4.xml · nonDerivative · entry 1

Guttman-McCabe Christopher · CIK 0001828490 · Chief Reg & Comm Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,020

F1 · shares: Represents shares sold pursuant to a 10b-5-1 trading plan adopted by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units granted August 2020.

Read SEC document
December 01, 2020 Filed Dec 4, 2020 00:32 UTC
Gangeri ElaineChief Acc Officer, Treasurer
SaleCommon Stock 1,018 $30.10 $30,641.80
Disclosure

SEC source: 0001209191-20-061672 · doc4.xml · nonDerivative · entry 1

Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,298

Read SEC document
November 23, 2020 Filed Nov 24, 2020 23:25 UTC PurchaseCommon Stock 2,000 $28.50 $57,000.00
Disclosure

SEC source: 0001209191-20-060317 · doc4.xml · nonDerivative · entry 1

DANIELS LESLIE B · CIK 0001052559 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,072

Read SEC document
November 19, 2020 Filed May 3, 2021 20:50 UTC
OBRIEN MORGAN EDirector · Executive Chairman
GiftCommon Stock 12,200 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-029650 · doc5.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,050

F1 · kind: These transactions represent gifts or charitable contributions by the Reporting Person.

Read SEC document
November 18, 2020 Filed Jun 23, 2021 01:46 UTC PurchaseCommon Stock 1,000 $28.56 $28,560.00
Disclosure

SEC source: 0001209191-21-042662 · doc4.xml · nonDerivative · entry 2

DANIELS LESLIE B · CIK 0001052559 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,072

Read SEC document
November 18, 2020 Filed Jun 23, 2021 01:46 UTC PurchaseCommon Stock 1,000 $29.06 $29,060.00
Disclosure

SEC source: 0001209191-21-042662 · doc4.xml · nonDerivative · entry 1

DANIELS LESLIE B · CIK 0001052559 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,072

Read SEC document
September 08, 2020 Filed Sep 8, 2020 18:14 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 4,635 $40.18 $186,225.49
Disclosure

SEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 3

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,250

F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.

F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $39.92 to $40.85. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 18:14 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 9,715 $42.30 $410,916.33
Disclosure

SEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 2

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,885

F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.

F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.00 to $42.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2020 Filed Sep 3, 2020 22:40 UTC
Schwartz Robert HarrisPresident and CEO
SaleCommon Stock 6,493 $42.70 $277,258.89
Disclosure

SEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 2

Schwartz Robert Harris · CIK 0001654170 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,850

F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016 and February 2020.

F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.22 to $42.7034. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 18:14 UTC
OBRIEN MORGAN EDirector · Executive Chairman
GrantStock Option (Right to Buy) · Derivative 26,464 $0.00 Strike: $46.85 $0.00
Disclosure

SEC source: 0001209191-20-049778 · doc4.xml · derivative · entry 4

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,464

Underlying: Common Stock · 26,464 shares

Expires 2025-08-29

F5 · balance_after: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the stock option.

Read SEC document
September 03, 2020 Filed Sep 8, 2020 18:14 UTC
OBRIEN MORGAN EDirector · Executive Chairman
GrantCommon Stock 26,009 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,600

F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.

Read SEC document
September 02, 2020 Filed Sep 2, 2020 22:22 UTC
Gray TimothyChief Financial Officer
SaleCommon Stock 3,338 $42.85 $143,034.30
Disclosure

SEC source: 0001209191-20-049245 · doc4.xml · nonDerivative · entry 2

Gray Timothy · CIK 0001629762 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,124

F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.

F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.62 to $43.255. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 22:20 UTC GrantCommon Stock 2,072 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049540 · doc4.xml · nonDerivative · entry 1

PRATT GREGORY A · CIK 0001094960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,301

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 22:16 UTC GrantCommon Stock 2,072 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049537 · doc4.xml · nonDerivative · entry 1

DANIELS LESLIE B · CIK 0001052559 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,072

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 18:17 UTC
Haller GregDirector
GrantCommon Stock 2,072 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049538 · doc4.xml · nonDerivative · entry 1

Haller Greg · CIK 0001756620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,776

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 22:14 UTC GrantCommon Stock 2,072 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049536 · doc4.xml · nonDerivative · entry 1

Akhavan Hamid · CIK 0001295252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,072

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 18:19 UTC GrantCommon Stock 2,763 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049539 · doc4.xml · nonDerivative · entry 1

MCALLISTER SINGLETON B · CIK 0001209079 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,908

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 18:21 UTC
SALEH PAUL NDirector
GrantCommon Stock 2,072 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049541 · doc4.xml · nonDerivative · entry 1

SALEH PAUL N · CIK 0001196630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,537

F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 22:40 UTC
Schwartz Robert HarrisPresident and CEO
GrantStock Option (Right to Buy) · Derivative 7,318 $0.00 Strike: $46.85 $0.00
Disclosure

SEC source: 0001209191-20-049552 · doc4.xml · derivative · entry 3

Schwartz Robert Harris · CIK 0001654170 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,318

Underlying: Common Stock · 7,318 shares

Expires 2025-08-29

F4 · balance_after: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported stock option.

Read SEC document
September 02, 2020 Filed Sep 3, 2020 22:40 UTC
Schwartz Robert HarrisPresident and CEO
GrantCommon Stock 10,128 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 1

Schwartz Robert Harris · CIK 0001654170 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,343

F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 18:19 UTC
MCAULEY BRIANDirector · Chairman Emeritus
SaleCommon Stock 3,246 $43.38 $140,812.78
Disclosure

SEC source: 0001209191-20-049244 · doc4.xml · nonDerivative · entry 2

MCAULEY BRIAN · CIK 0001014804 · Director · Chairman Emeritus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,840

F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.

F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.38 to $43.495. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 22:22 UTC
Gray TimothyChief Financial Officer
GrantCommon Stock 5,849 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049245 · doc4.xml · nonDerivative · entry 1

Gray Timothy · CIK 0001629762 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,462

F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.

Read SEC document
August 31, 2020 Filed Sep 2, 2020 18:19 UTC
MCAULEY BRIANDirector · Chairman Emeritus
GrantCommon Stock 5,784 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-049244 · doc4.xml · nonDerivative · entry 1

MCAULEY BRIAN · CIK 0001014804 · Director · Chairman Emeritus

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,086

F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.

Read SEC document
August 25, 2020 Filed Aug 27, 2020 21:30 UTC
Ashe Gena LGeneral Counsel & Secretary
SaleCommon Stock 493 $44.80 $22,086.65
Disclosure

SEC source: 0001209191-20-048552 · doc4.xml · nonDerivative · entry 1

Ashe Gena L · CIK 0001669943 · General Counsel & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,706

F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted July 2019.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $44.88. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 25, 2020 Filed Aug 27, 2020 21:31 UTC
Gangeri ElaineChief Acc Officer, Asst Sect
SaleCommon Stock 1,641 $44.80 $73,518.93
Disclosure

SEC source: 0001209191-20-048553 · doc4.xml · nonDerivative · entry 1

Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,316

F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and July 2019.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $45.16. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 00:13 UTC
Schwartz Robert HarrisPresident and CEO
SaleCommon Stock 409 $47.03 $19,235.68
Disclosure

SEC source: 0001209191-20-047841 · doc4.xml · nonDerivative · entry 1

Schwartz Robert Harris · CIK 0001654170 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,215

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.00 to $47.15. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 20:23 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 3,030 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001209191-20-047649 · doc4.xml · derivative · entry 3

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 3,030 shares

Expires 2024-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shares are fully vested.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 20:23 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 3,030 $44.76 $135,625.83
Disclosure

SEC source: 0001209191-20-047649 · doc4.xml · nonDerivative · entry 2

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,591

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the exercise of stock options.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.52 to $45.11. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 20:23 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionCommon Stock 3,030 $20.00 $60,600.00
Disclosure

SEC source: 0001209191-20-047649 · doc4.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 17, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 8,162 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · derivative · entry 9

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,030

Underlying: Common Stock · 8,162 shares

Expires 2024-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option shares are fully vested.

Read SEC document
August 17, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 8,162 $44.69 $364,735.29
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 7

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,591

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options.

F6 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.28 to $45.19. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 17, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionCommon Stock 8,162 $20.00 $163,240.00
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 6

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 8,808 $0.00 Strike: $20.00 $0.00
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · derivative · entry 8

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,192

Underlying: Common Stock · 8,808 shares

Expires 2024-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option shares are fully vested.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 2,775 $45.21 $125,460.53
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 5

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,591

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options.

F5 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $45.00 to $45.48. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 6,572 $44.49 $292,401.42
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 4

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,366

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options.

F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.98 to $44.92. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 14, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
Exercise / conversionCommon Stock 8,808 $20.00 $176,160.00
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 3

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 200 $44.93 $8,985.00
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 2

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,130

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options.

F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.92 to $44.93. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
August 13, 2020 Filed Aug 17, 2020 19:06 UTC
OBRIEN MORGAN EDirector · Executive Chairman
SaleCommon Stock 7,835 $44.48 $348,477.30
Disclosure

SEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,330

F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options.

F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.90 to $44.90. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 19:18 UTC
OBRIEN MORGAN EDirector · Chief Executive Officer
GrantCommon Stock 40,065 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-039181 · doc4.xml · nonDerivative · entry 1

OBRIEN MORGAN E · CIK 0000937846 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,165

F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs will vest in full on July 1, 2021.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 23:17 UTC GrantCommon Stock 229 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-039180 · doc4.xml · nonDerivative · entry 1

PRATT GREGORY A · CIK 0001094960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229

F1 · shares: The restricted stock vests in full on August 6, 2020; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy.

Read SEC document
June 24, 2020 Filed Jun 26, 2020 23:19 UTC
Schwartz Robert HarrisPresident and COO
GrantStock Option (Right to Buy) · Derivative 60,558 $0.00 Strike: $49.92 $0.00
Disclosure

SEC source: 0001209191-20-039182 · doc4.xml · derivative · entry 1

Schwartz Robert Harris · CIK 0001654170 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,558

Underlying: Common Stock · 60,558 shares

Expires 2030-06-24

F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on July 1, 2021 with the remaining shares vesting in 3 equal annual installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.